{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:24:19Z","timestamp":1741325059623,"version":"3.38.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2025.105715","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:30:41Z","timestamp":1736397041000},"page":"105715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Indolent clonal lymphoid disorders"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5023-0689","authenticated-orcid":false,"given":"Jan","family":"Delabie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sakhdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.humpath.2025.105715_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","article-title":"Monoclonal B lymphocytes with the characteristics of \"indolent\" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","article-title":"Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach","volume":"114","author":"Nieto","year":"2009","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2025.105715_bib4","first-page":"S10","article-title":"Prevalence of monoclonal B-cell lymphocytosis: a systematic review","volume":"78","author":"Shim","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"7","key":"10.1016\/j.humpath.2025.105715_bib5","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3026(16)30192-2","article-title":"Monoclonal B-cell lymphocytosis in a hospital-based UK population and a rural Ugandan population: a cross-sectional study","volume":"4","author":"Rawstron","year":"2017","journal-title":"Lancet Haematol"},{"issue":"15","key":"10.1016\/j.humpath.2025.105715_bib6","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood.2020006322","article-title":"Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families","volume":"137","author":"Slager","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/gcc.22234","article-title":"Immunophenotypic analysis reveals heterogeneity and common biologic aspects in monoclonal B-cell lymphocytosis","volume":"54","author":"Kostopoulos","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2025.105715_bib8","first-page":"S19","article-title":"Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)","volume":"78","author":"Rawstron","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"24","key":"10.1016\/j.humpath.2025.105715_bib9","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.2008.21.2704","article-title":"Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia","volume":"27","author":"Shanafelt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.humpath.2025.105715_bib10","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1182\/blood-2012-12-471698","article-title":"Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL","volume":"121","author":"Vardi","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2016.172","article-title":"Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome","volume":"31","author":"Barrio","year":"2017","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.humpath.2025.105715_bib13","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1309\/AJCPPHSUQM8XBJH7","article-title":"Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns","volume":"139","author":"Randen","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/AJCPD5TOBDJU4GKO","article-title":"Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations","volume":"141","author":"Nelson","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2025.105715_bib16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3324\/haematol.2011.042333","article-title":"Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis","volume":"96","author":"Gibson","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.humpath.2025.105715_bib17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.5858\/arpa.2020-0654-OA","article-title":"A tissue counterpart to monoclonal B-cell lymphocytosis","volume":"145","author":"Habermehl","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2559.2011.03897.x","article-title":"Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes","volume":"59","author":"Henopp","year":"2011","journal-title":"Histopathology."},{"issue":"2","key":"10.1016\/j.humpath.2025.105715_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3960\/jslrt.23010","article-title":"Precursory or early lesions of follicular lymphoma: clinical features, pathology, and genetics","volume":"63","author":"Oishi","year":"2023","journal-title":"J Clin Exp Hematop"},{"issue":"12","key":"10.1016\/j.humpath.2025.105715_bib20","first-page":"2271","article-title":"Bcl-2\/JH rearrangements in benign lymphoid tissues with follicular hyperplasia","volume":"6","author":"Limpens","year":"1991","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.humpath.2025.105715_bib21","doi-asserted-by":"crossref","first-page":"8910","DOI":"10.1073\/pnas.91.19.8910","article-title":"BCL2 translocation frequency rises with age in humans","volume":"91","author":"Liu","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.humpath.2025.105715_bib22","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404035","article-title":"Long-term clonal persistence and evolution of t(14;18)-bearing B cells in healthy individuals","volume":"20","author":"Roulland","year":"2006","journal-title":"Leukemia"},{"issue":"4720","key":"10.1016\/j.humpath.2025.105715_bib24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178503","article-title":"Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia","volume":"12","author":"Kosmidis","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.humpath.2025.105715_bib26","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3324\/haematol.2020.254854","article-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","volume":"106","author":"Vogelsberg","year":"2021","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.humpath.2025.105715_bib27","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2018-03-837039","article-title":"CREBBP gene mutations are frequently detected in in situ follicular neoplasia","volume":"132","author":"Schmidt","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.5861","article-title":"Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma","volume":"256","author":"Dobson","year":"2022","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2025.105715_bib29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000000628","article-title":"Incidental and isolated follicular lymphoma in situ and mantle cell lymphoma in situ lack clinical significance","volume":"40","author":"Bermudez","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib30","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","author":"Jegalian","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.humpath.2025.105715_bib31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.pas.0000173233.29741.38","article-title":"Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage","volume":"29","author":"Adam","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2025.105715_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5009\/gnl210300","article-title":"Primary gastrointestinal follicular lymphomas: a prospective study of 31 patients with long-term follow-up registered in the French gastrointestinal lymphoma study group (geld) of the French federation of digestive oncology (ffcd)","volume":"16","author":"Matysiak-Budnik","year":"2022","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib35","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1038\/s41598-023-32736-9","article-title":"Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy","volume":"13","author":"Iwamuro","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.humpath.2025.105715_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib37","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/leu.2009.31","article-title":"t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals","volume":"23","author":"Lecluse","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3960\/jslrt.20022","article-title":"An overlapping case of in situ mantle cell neoplasia and leukemic non-nodal mantle cell lymphoma","volume":"60","author":"Matsuoka","year":"2020","journal-title":"J Clin Exp Hematop"},{"issue":"12","key":"10.1016\/j.humpath.2025.105715_bib39","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/modpathol.2012.117","article-title":"Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues","volume":"25","author":"Adam","year":"2012","journal-title":"Mod Pathol"},{"issue":"15","key":"10.1016\/j.humpath.2025.105715_bib40","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1182\/blood-2010-10-299628","article-title":"How I treat: diagnosing and managing \"in situ\" lymphoma","volume":"117","author":"Carbone","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finist\u00e8re, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"issue":"13","key":"10.1016\/j.humpath.2025.105715_bib42","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","article-title":"Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden","volume":"123","author":"Turesson","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.humpath.2025.105715_bib45","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3324\/haematol.2022.282389","article-title":"IgM monoclonal gammopathy of undetermined significance: clinicopathologic features with and without IgM-related disorders","volume":"108","author":"Bruehl","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2025.105715_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-5-38","article-title":"The Schnitzler syndrome","volume":"5","author":"Lipsker","year":"2010","journal-title":"Orphanet J Rare Dis"},{"year":"2024","series-title":"Haematolymphoid tumours","key":"10.1016\/j.humpath.2025.105715_bib47"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib48","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international Consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2025.105715_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221941","article-title":"Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenstr\u00f6m's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance","volume":"14","author":"Nakamura","year":"2019","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.humpath.2025.105715_bib50","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1182\/blood-2013-07-513366","article-title":"MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance","volume":"122","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2025.105715_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.602868","article-title":"B-Cell-Specific Myd88 L252P expression causes a premalignant gammopathy resembling IgM MGUS","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front Immunol"},{"issue":"26","key":"10.1016\/j.humpath.2025.105715_bib52","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2014-03-564583","article-title":"C1013G\/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma","volume":"123","author":"Roccaro","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1006\/jmbi.1996.0110","article-title":"The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3","volume":"256","author":"Li","year":"1996","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib54","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10428190701385173","article-title":"Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas","volume":"48","author":"Hauswirth","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"15","key":"10.1016\/j.humpath.2025.105715_bib55","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune hemolytic anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib56","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3324\/haematol.2013.091702","article-title":"Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma","volume":"99","author":"Randen","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib58","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.15063","article-title":"Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease","volume":"183","author":"Ma\u0142ecka","year":"2018","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.humpath.2025.105715_bib59","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1002\/ajh.26205","article-title":"The mutational landscape of cold agglutinin disease: CARD11 and CXCR4 mutations are correlated with lower hemoglobin levels","volume":"96","author":"Ma\u0142ecka","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2025.105715_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-024-01569-8","article-title":"Cold-antibody autoimmune hemolytic anemia: its association with neoplastic disease and impact on therapy","author":"Berentsen","year":"2024","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib61","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.humpath.2025.105715_bib62","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","article-title":"Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation","volume":"116","author":"Takeuchi","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00000478-200604000-00017","article-title":"Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease","volume":"30","author":"Vega","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib64","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/10668969221113474","article-title":"Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract - a report of two cases of a new provisional entity on the world health organization classification of hematolymphoid tumors","volume":"31","author":"Alves de Castro","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2025.105715_bib65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/PAS.0000000000000443","article-title":"Clinicopathologic analysis of 6 lymphomatoid gastropathy cases: expanding the disease spectrum to CD4-CD8+ cases","volume":"39","author":"Takata","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2025.105715_bib66","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.2019001443","article-title":"Recurrent somatic JAK3 mutations in NK-cell enteropathy","volume":"134","author":"Xiao","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update","volume":"35","author":"Matnani","year":"2017","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.semdp.2019.08.001","article-title":"Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders","volume":"37","author":"Soderquist","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1159\/000511473","article-title":"The clinical spectrum of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoproliferative disorder: an updated systematic literature review and case series","volume":"237","author":"Surmanowicz","year":"2021","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib70","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.12788\/j.sder.2018.006","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Gru","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"7","key":"10.1016\/j.humpath.2025.105715_bib73","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French cutaneous lymphoma study group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105715_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3109\/10428194.2014.938331","article-title":"CD4 + primary cutaneous small\/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature","volume":"56","author":"James","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/bjd\/ljae192","article-title":"Mutational profiling of primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorder does not resemble nodal peripheral T-cell lymphomas with a follicular helper T-cell phenotype","volume":"191","author":"Rodr\u00edguez","year":"2024","journal-title":"Br J Dermatol"},{"issue":"16","key":"10.1016\/j.humpath.2025.105715_bib76","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib77","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1203475417715209","article-title":"Primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoproliferative disorder: a case series","volume":"21","author":"Maurelli","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.humpath.2025.105715_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib79","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cup.13020","article-title":"Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: a long-standing case with an unexpected progression","volume":"44","author":"Alberti-Violetti","year":"2017","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105715_bib80","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0560.2009.01278.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?","volume":"37","author":"Beltraminelli","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2025.105715_bib81","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cup.13517","article-title":"Primary cutaneous acral CD8+ T-cell lymphoma of the ear: a case report","volume":"46","author":"Ormerod","year":"2019","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib82","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e3182a74c7a","article-title":"Multicenter case series of indolent small\/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face","volume":"36","author":"Li","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.humpath.2025.105715_bib83","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20973","article-title":"Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop","volume":"186","author":"Kempf","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.humpath.2025.105715_bib84","article-title":"Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder","volume":"27","author":"Wobse","year":"2024","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib85","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ijd.13340","article-title":"Long-term follow-up and management of small and medium-sized CD4+ T cell lymphoma and CD8+ lymphoid proliferations of acral sites: a multicenter experience","volume":"55","author":"Virmani","year":"2016","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.humpath.2025.105715_bib86","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.15572","article-title":"Primary cutaneous acral CD8+ T-cell lymphomas relapse more frequently in younger patients","volume":"185","author":"Maubec","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.humpath.2025.105715_bib87","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.5858\/arpa.2017-0230-RA","article-title":"Primary cutaneous acral CD8+ T-cell lymphoma","volume":"141","author":"Hathuc","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.humpath.2025.105715_bib88","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:41:55Z","timestamp":1741297315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":88,"alternative-id":["S0046817725000024"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105715","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indolent clonal lymphoid disorders","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105715"}}